Health Catalyst (HCAT) Common Equity (2018 - 2025)
Historic Common Equity for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $331.9 million.
- Health Catalyst's Common Equity fell 651.03% to $331.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $331.9 million, marking a year-over-year decrease of 651.03%. This contributed to the annual value of $365.2 million for FY2024, which is 46.66% down from last year.
- Per Health Catalyst's latest filing, its Common Equity stood at $331.9 million for Q3 2025, which was down 651.03% from $347.5 million recorded in Q2 2025.
- Health Catalyst's 5-year Common Equity high stood at $549.2 million for Q3 2021, and its period low was $268.8 million during Q1 2021.
- For the 5-year period, Health Catalyst's Common Equity averaged around $392.9 million, with its median value being $376.8 million (2025).
- In the last 5 years, Health Catalyst's Common Equity skyrocketed by 8909.81% in 2021 and then crashed by 1989.05% in 2022.
- Quarter analysis of 5 years shows Health Catalyst's Common Equity stood at $522.1 million in 2021, then decreased by 18.6% to $425.0 million in 2022, then fell by 13.67% to $366.9 million in 2023, then dropped by 0.47% to $365.2 million in 2024, then dropped by 9.11% to $331.9 million in 2025.
- Its Common Equity stands at $331.9 million for Q3 2025, versus $347.5 million for Q2 2025 and $376.8 million for Q1 2025.